The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.
Biopharmaceutical Parameters to Consider in Order to Alter The Fate of Nanocarriers After Oral Delivery
Abstract
Oral route is the most common route for the delivery of drugs because it is simple to implement and improves patient compliance and quality of life. However, oral absorption is limited by various physiological barriers and remains a scientific challenge. Nanometric-sized drug delivery systems are being extensively studied and provide promising potential for oral drug delivery. Many different technological solutions have been proposed to enhance the bioavailability or the targeting of drug after oral administration. To reach these goals, it is important to analyze the biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. In the present review, the gastrointestinal barrier and physiological stress factors with regard to nanocarriers' performance or integrity issues are first described. Second, the different characteristics offered by the nanocarriers (size, surface composition and properties mediated by external factors such as ligands) and their effect on the optimal transport of drug into the bloodstream are discussed. Finally, the integrity issue is discussed in function of the expected role of the nanocarriers: bioavailability enhancement or pharmacological targeting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
REJMAN, J., OBERLE, V., ZUHORN, I. S., & HOEKSTRA, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,864
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Chithrani, B. D., & Chan, W. C. W. (2007) · Nano Letters · doi:10.1021/nl070363y · Cited by 2,286
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Yin Win, K., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.050 · Cited by 1,452
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER
Pelkmans, L., Kartenbeck, J., & Helenius, A. (2001) · Nature Cell Biology · doi:10.1038/35074539 · Cited by 1,235
Mechanics of receptor-mediated endocytosis
Gao, H., Shi, W., & Freund, L. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503879102 · Cited by 1,217
Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms
Dressman, J. B., Amidon, G. L., Reppas, C., & Shah, V. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011984216775 · Cited by 1,097
Nanosizing — Oral formulation development and biopharmaceutical evaluation
Kesisoglou, F., Panmai, S., & Wu, Y. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.003 · Cited by 1,055
Panyam, J., Zhou, W., Prabha, S., Sahoo, S. K., & Labhasetwar, V. (2002) · The FASEB Journal · doi:10.1096/fj.02-0088com · Cited by 1,044
Endocytic mechanisms for targeted drug delivery☆
BAREFORD, L., & SWAAN, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.008 · Cited by 1,033
Functional polymer microspheres
Kawaguchi, H. (2000) · Progress in Polymer Science · doi:10.1016/s0079-6700(00)00024-1 · Cited by 947
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
Desai, M. P., Labhasetwar, V., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 941
Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs
Galia, E., Nicolaides, E., Hörter, D., Löbenberg, R., Reppas, C., & Dressman, J. B. (1998) · Pharmaceutical Research · doi:10.1023/a:1011910801212 · Cited by 927
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb07033.x · Cited by 920
Schnitzer, J. E., Oh, P., Pinney, E., & Allard, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.5.1217 · Cited by 919
GADDUM, J. H. (1955) · Nature · doi:10.1038/1761186b0 · Cited by 900
Endocytosis by random initiation and stabilization of clathrin-coated pits
Ehrlich, M., Boll, W., van Oijen, A., Hariharan, R., Chandran, K., Nibert, M. L., & Kirchhausen, T. (2004) · Cell · doi:10.1016/j.cell.2004.08.017 · Cited by 843
Hörter, D., & Dressman, J. B. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00130-7 · Cited by 819
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer
Morille, M., Passirani, C., Vonarbourg, A., Clavreul, A., & Benoit, J.-P. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.036 · Cited by 769
Self-citationDissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An Update
Jantratid, E., Janssen, N., Reppas, C., & Dressman, J. B. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9569-4 · Cited by 764
Potocytosis: Sequestration and Transport of Small Molecules by Caveolae
Anderson, R. G. W., Kamen, B. A., Rothberg, K. G., & Lacey, S. W. (1992) · Science · doi:10.1126/science.1310359 · Cited by 735
Role of nanotechnology in targeted drug delivery and imaging: a concise review
Koo, O. M., Rubinstein, I., & Onyuksel, H. (2005) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.06.004 · Cited by 718
Pan, Y., Li, Y.-J., Zhao, H.-Y., Zheng, J.-M., Xu, H., Wei, G., Hao, J.-S., & Cui, F.-D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00486-6 · Cited by 686
Transcytosis: Crossing Cellular Barriers
TUMA, P. L., & HUBBARD, A. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00001.2003 · Cited by 681
Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles
Li, H., Zhao, X., Ma, Y., Zhai, G., Li, L., & Lou, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.002 · Cited by 666
Kalantzi, L., Goumas, K., Kalioras, V., Abrahamsson, B., Dressman, J. B., & Reppas, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-8476-1 · Cited by 658
Jung, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00084-9 · Cited by 588
A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers
Heurtault, B., Saulnier, P., Pech, B., Proust, J.-E., & Benoit, J.-P. (2002) · Pharmaceutical Research · doi:10.1023/a:1016121319668 · Cited by 583
Self-citationOptimized conditions for prediction of intestinal drug permeability using Caco-2 cells
Yamashita, S., Furubayashi, T., Kataoka, M., Sakane, T., Sezaki, H., & Tokuda, H. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00076-2 · Cited by 568
Wileman, T., Harding, C., & Stahl, P. (1985) · Biochemical Journal · doi:10.1042/bj2320001 · Cited by 565
Targeting of nanoparticles to the clathrin-mediated endocytic pathway
Harush-Frenkel, O., Debotton, N., Benita, S., & Altschuler, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.135 · Cited by 564
Lennernaäs, H. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970332a · Cited by 500
The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
Florence, A. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012029517394 · Cited by 499
Ponchel, G. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00040-4 · Cited by 494
Mucoadhesive nanoparticulate systems for peptide drug delivery
Takeuchi, H., Yamamoto, H., & Kawashima, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00120-4 · Cited by 488
Panyam, J., & Labhasetwar, V. (2003) · Pharmaceutical Research · doi:10.1023/a:1022219003551 · Cited by 466
Rab GTPases coordinate endocytosis
Rodman, J. S., & Wandinger-Ness, A. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.2.183 · Cited by 450
Lipid-Based Delivery Systems and Intestinal Lymphatic Drug Transport: A Mechanistic Update
Trevaskis, N. L., Charman, W. N., & Porter, C. J. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.007 · Cited by 442
Mucoadhesive nanoparticulate systems for peptide drug delivery.
Takéuchi, Hirofumi, Yamamoto, Y., Hiromitsu, Kawashima, & Yoshiaki (2002) · 岐阜藥科大學紀要 = The annual proceedings of Gifu College of Pharmacy · Cited by 432
Montesano, R., Roth, J., Robert, A., & Orci, L. (1982) · Nature · doi:10.1038/296651a0 · Cited by 426
The uptake and intracellular fate of PLGA nanoparticles in epithelial cells
Cartiera, M. S., Johnson, K. M., Rajendran, V., Caplan, M. J., & Saltzman, W. M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.057 · Cited by 412
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability
Luo, Y., Chen, D., Ren, L., Zhao, X., & Qin, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.010 · Cited by 395
Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract
Hörter, D., & Dressman, J. B. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00487-5 · Cited by 393
Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A
El-Shabouri, M. H. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00461-1 · Cited by 392
Cui, F., Shi, K., Zhang, L., Tao, A., & Kawashima, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.013 · Cited by 391
Caveosomes and endocytosis of lipid rafts
Nichols, B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00840 · Cited by 389
Manjunath, K., & Venkateswarlu, V. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.006 · Cited by 380
Behrens, I., Pena, A. I. V., Alonso, M. J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019854327540 · Cited by 372
Tobı́o, M., Sánchez, A., Vila, A., Soriano, I., Evora, C., Vila-Jato, J. L., & Alonso, M. J. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00157-5 · Cited by 368
VERTZONI, M., DRESSMAN, J., BUTLER, J., HEMPENSTALL, J., & REPPAS, C. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.03.002 · Cited by 358
Preparation and Characterization of Nanoparticles Shelled with Chitosan for Oral Insulin Delivery
Lin, Y.-H., Mi, F.-L., Chen, C.-T., Chang, W.-C., Peng, S.-F., Liang, H.-F., & Sung, H.-W. (2007) · Biomacromolecules · doi:10.1021/bm0607776 · Cited by 349
Transmucosal macromolecular drug delivery
Prego, C., García, M., Torres, D., & Alonso, M. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.030 · Cited by 338
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.021 · Cited by 331
Bravo-Osuna, I., Vauthier, C., Farabollini, A., Palmieri, G. F., & Ponchel, G. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.01.005 · Cited by 325
M Cells in Peyer's Patches of the Intestine
Gebert, A., Rothkötter, H.-J., & Pabst, R. (1996) · International Review of Cytology · doi:10.1016/s0074-7696(08)61346-7 · Cited by 320
Rieux, A. D., Ragnarsson, E. G. E., Gullberg, E., Préat, V., Schneider, Y.-J., & Artursson, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.015 · Cited by 298
Uster, P. S., Allen, T. M., Daniel, B. E., Mendez, C. J., Newman, M. S., & Zhu, G. Z. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00452-8 · Cited by 298
In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery
Sonaje, K., Lin, Y.-H., Juang, J.-H., Wey, S.-P., Chen, C.-T., & Sung, H.-W. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.066 · Cited by 295
A dynamic in vitro lipolysis model
Zangenberg, N. H., Müllertz, A., Kristensen, H. G., & Hovgaard, L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00169-5 · Cited by 287
Intestinal Drug Absorption and Metabolism in Cell Cultures: Caco-2 and Beyond
Artursson, P., & Borchardt, R. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012155124489 · Cited by 280
Regulation of raft‐dependent endocytosis
Lajoie, P., & Nabi, I. R. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00083.x · Cited by 279
Peltier, S., Oger, J.-M., Lagarce, F., Couet, W., & Benoît, J.-P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0022-2 · Cited by 274
Self-citationDesign of lipid nanoparticles for the oral delivery of hydrophilic macromolecules
Garcı́a-Fuentes, M., Torres, D., & Alonso, M. J. (2003) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(02)00053-x · Cited by 273
Expression of specific markers and particle transport in a new human intestinal M-cell model
Gullberg, E., Leonard, M., Karlsson, J., Hopkins, A. M., Brayden, D., Baird, A. W., & Artursson, P. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4038 · Cited by 270
Ma, Z., & Lim, L.-Y. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003379.76417.3e · Cited by 265
Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.010 · Cited by 265
Self-citationThe effect of physical barriers and properties on the oral absorption of particulates
Norris, D. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00037-4 · Cited by 262
Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate
Florence, A. T., Hillery, A. M., Hussain, N., & Jani, P. U. (1995) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00059-h · Cited by 260
Hariharan, S., Bhardwaj, V., Bala, I., Sitterberg, J., Bakowsky, U., & Ravi Kumar, M. N. V. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-8418-y · Cited by 257
Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity
Jevprasesphant, R., Penny, J., Attwood, D., McKeown, N. B., & D'Emanuele, A. (2003) · Pharmaceutical Research · doi:10.1023/a:1026166729873 · Cited by 256
Park, J. S., Han, T. H., Lee, K. Y., Han, S. S., Hwang, J. J., Moon, D. H., Kim, S. Y., & Cho, Y. W. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.011 · Cited by 250
Nanoparticle uptake by the oral route: Fulfilling its potential?
Florence, A. T. (2005) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2005.05.019 · Cited by 248
Kalaria, D. R., Sharma, G., Beniwal, V., & Ravi Kumar, M. N. V. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9763-4 · Cited by 246
Exploiting M cells for drug and vaccine delivery
Clark, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00149-1 · Cited by 246
Sahu, A., Bora, U., Kasoju, N., & Goswami, P. (2008) · Acta Biomaterialia · doi:10.1016/j.actbio.2008.04.021 · Cited by 239
Clathrin‐Dependent or Not: Is It Still the Question?
Johannes, L., & Lamaze, C. (2002) · Traffic · doi:10.1034/j.1600-0854.2002.30701.x · Cited by 239
Vertzoni, M., Fotaki, N., Nicolaides, E., Reppas, C., Kostewicz, E., Stippler, E., Leuner, C., & Dressman, J. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022935 · Cited by 236
The role of enterocytes in the intestinal barrier function and antigen uptake
Snoeck, V., Goddeeris, B., & Cox, E. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.04.003 · Cited by 232
Enhancing paracellular permeability by modulating epithelial tight junctions
Ward, P. D., Tippin, T. K., & Thakker, D. R. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00302-3 · Cited by 227
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting
Brayden, D. J., Jepson, M. A., & Baird, A. W. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03536-1 · Cited by 224
SADEGHI, A., DORKOOSH, F., AVADI, M., WEINHOLD, M., BAYAT, A., DELIE, F., GURNY, R., LARIJANI, B., RAFIEETEHRANI, M., & JUNGINGER, H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.03.004 · Cited by 223
Oral Drug Absorption: Prediction and Assessment
Dressman, J., & Lennernäs, H. (2000) · Medical Entomology and Zoology · Cited by 217
Kumar, V. V., Chandrasekar, D., Ramakrishna, S., Kishan, V., Rao, Y. M., & Diwan, P. V. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.004 · Cited by 213
Enzymatic degradation of SLN—effect of surfactant and surfactant mixtures
Olbrich, C., & Müller, R. H. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00404-9 · Cited by 208
Nanoparticles for Drug Delivery
(2021) · Gels Horizons: From Science to Smart Materials · doi:10.1007/978-981-16-2119-2 · Cited by 203
Efficient polyethylenimine-mediated gene delivery proceeds via a caveolar pathway in HeLa cells
Gabrielson, N. P., & Pack, D. W. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.02.003 · Cited by 202
Physiological Pharmaceutics: Barriers to Drug Absorption
WILSON, C. G., Washington, N., & Washington, C. (2000) · Cited by 199
Polymeric micelles for oral drug delivery: Why and how
Francis, M. F., Cristea, M., & Winnik, F. M. (2004) · Pure and Applied Chemistry · doi:10.1351/pac200476071321 · Cited by 197
A dynamic in vitro lipolysis model
Zangenberg, N. H., Müllertz, A., Gjelstrup Kristensen, H., & Hovgaard, L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00182-8 · Cited by 194
Design of nanoparticles composed of graft copolymers for oral peptide delivery
Sakuma, S., Hayashi, M., & Akashi, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00119-8 · Cited by 194
Lin, Y.-H., Sonaje, K., Lin, K. M., Juang, J.-H., Mi, F.-L., Yang, H.-W., & Sung, H.-W. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.020 · Cited by 194
Enhanced Oral Uptake of Tomato Lectin-Conjugated Nanoparticles in the Rat
Hussain, N., Jani, P. U., & Florence, A. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012153011884 · Cited by 191
The influence of lipid nanocapsule composition on their size distribution
Heurtault, B., Saulnier, P., Pech, B., Venier-Julienne, M.-C., Proust, J.-E., Phan-Tan-Luu, R., & Benoı̂t, J.-P. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00241-5 · Cited by 186
Endocytosis and Interaction of Poly (Amidoamine) Dendrimers with Caco-2 Cells
Kitchens, K. M., Foraker, A. B., Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9415-0 · Cited by 182
Transepithelial and endothelial transport of poly (amidoamine) dendrimers
KITCHENS, K., ELSAYED, M., & GHANDEHARI, H. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.013 · Cited by 177
Studies on oral absorption of stearic acid SLN by a novel fluorometric method
Yuan, H., Chen, J., Du, Y.-Z., Hu, F.-Q., Zeng, S., & Zhao, H.-L. (2007) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2007.03.002 · Cited by 176
Mucoadhesives in the gastrointestinal tract: revisiting the literature for novel applications
Dodou, D., Breedveld, P., & Wieringa, P. A. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.01.007 · Cited by 175
Enhanced Oral Bioavailability of Doxorubicin in a Dendrimer Drug Delivery System
Ke, W., Zhao, Y., Huang, R., Jiang, C., & Pei, Y. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21155 · Cited by 165
Salamat‐Miller, N., & Johnston, T. P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.022 · Cited by 164
Oral delivery of insulin by using surface coating liposomes
Iwanaga, K., Ono, S., Narioka, K., Morimoto, K., Kakemi, M., Yamashita, S., Nango, M., & Oku, N. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00237-8 · Cited by 160
Kalantzi, L., Persson, E., Polentarutti, B., Abrahamsson, B., Goumas, K., Dressman, J. B., & Reppas, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0207-8 · Cited by 159
(B) Mechanisms of peptide and protein absorption
Nellans, H. N. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90013-3 · Cited by 157
Kitchens, K. M., Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700089s · Cited by 157
Iwanaga, K., Ono, S., Narioka, K., Kakemi, M., Morimoto, K., Yamashita, S., Namba, Y., & Oku, N. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980235x · Cited by 157
Mucoadhesive chitosan-coated liposomes: characteristics and stability
Filipović‐Grčić, J., Škalko‐Basnet, N., & JALŠIENJAK, I. (2001) · Journal of Microencapsulation · doi:10.1080/026520401750038557 · Cited by 155
Biodegradation of solid lipid nanoparticles as a function of lipase incubation time
Müller, R. H., Rühl, D., & Runge, S. (1996) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04731-x · Cited by 155
The stability of liposomes in vitro to pH, bile salts and pancreatic lipase
Rowland, R. N., & Woodley, J. F. (1980) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(80)90131-9 · Cited by 154
Polymeric Particulates to Improve Oral Bioavailability of Peptide Drugs
Delié, F., & Blanco‐Prieto, M. J. (2005) · Molecules · doi:10.3390/10010065 · Cited by 150
Sant, V. P., Smith, D. C., & Leroux, J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.010 · Cited by 147
Mi, F., Wu, Y.-Y., Lin, Y.-H., Sonaje, K., Ho, Y., Chen, C.-T., Juang, J.-H., & Sung, H. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800076n · Cited by 146
Drug Delivery and Targeting : For Pharmacists and Pharmaceutical Scientists
Hillery, A. M., Lloyd, A. W., & Swarbrick, J. (2001) · Cited by 144
Clathrin‐Coated Pits: Vive La Différence?
Benmerah, A., & Lamaze, C. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00585.x · Cited by 143
Batrakova, E. V., Han, H.-Y., Miller, D. W., & Kabanov, A. V. (1998) · Pharmaceutical Research · doi:10.1023/a:1011942814300 · Cited by 141
Nanoparticle strategies for the oral delivery of insulin
Damgé, C., Reis, C. P., & Maincent, P. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.1.45 · Cited by 140
M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B
Gupta, P. N., Khatri, K., Goyal, A. K., Mishra, N., & Vyas, S. P. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701637982 · Cited by 136
Kokkona, M., Kallinteri, P., Fatouros, D. G., & Antimisiaris, S. G. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00064-0 · Cited by 133
In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery
Chen, F., Zhang, Z., Yuan, F., Qin, X., Wang, M., & Huang, Y. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.035 · Cited by 131
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery
Jepson, M. A., Clark, M. A., & Hirst, B. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.018 · Cited by 130
Targeting polymerised liposome vaccine carriers to intestinal M cells
Clark, M. A., Blair, H. J., Liang, L., Brey, R. N., Brayden, D. J., & Hirst, B. H. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00258-4 · Cited by 130
Maincent, P., Verge, R. L., Sado, P. A., Couvreur, P., & Devissaguet, J. P. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600751009 · Cited by 127
Hydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxel
Kim, S., Kim, J. Y., Huh, K. M., Acharya, G. S., & Park, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.004 · Cited by 127
Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery
Vauthier, C., Labarre, D., & Ponchel, G. (2007) · Journal of drug targeting · doi:10.1080/10611860701603372 · Cited by 126
Intestinal translocation of particulates — implications for drug and antigen delivery
O’Hagan, D. T. (1990) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(90)90020-s · Cited by 122
Fagerholm, U., & Lennernäs, H. (1995) · European Journal of Pharmaceutical Sciences · doi:10.1016/0928-0987(95)00027-b · Cited by 116
Gaumet, M., Gurny, R., & Delie, F. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.11.015 · Cited by 115
Kilpatrick, D. C., Pusztai, A. J., Grant, G., Graham, C., & Ewen, S. W. B. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80927-3 · Cited by 114
Pharmaceutical evaluation of genistein-loaded pluronic micelles for oral delivery
Kwon, S. H., Kim, S., Ha, K. W., Kang, M. J., Huh, J. S., Im, T.-J., Kim, Y. M., Park, Y. M., Kang, K. H., Lee, S. K., et al. (2007) · Archives of Pharmacal Research · doi:10.1007/bf02980249 · Cited by 114
Yoo, H. S., & Park, T. G. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10573 · Cited by 110
Yin, Y.-S., Chen, D., Qiao, M., Wei, X., & Hu, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.024 · Cited by 109
Vitamin B12-mediated transport of nanoparticles across Caco-2 cells
Russell-Jones, G. J., Arthur, L., & Walker, H. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00394-9 · Cited by 106
The gastrointestinal stability of lipid nanocapsules
Roger, E., Lagarce, F., & Benoît, J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.05.069 · Cited by 105
Self-citationThe importance of gastrointestinal uptake of particles in the design of oral delivery systems
Lavelle, E. C., Sharif, S., Thomas, N. W., Holland, J., & Davis, S. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00048-c · Cited by 103
Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor
Li, H. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00158-3 · Cited by 102
Transport Of Surface‐Modified Nanoparticles Through Cell Monolayers
Koch, A., Reynolds, F., Merkle, H. P., Weissleder, R., & Josephson, L. (2005) · ChemBioChem · doi:10.1002/cbic.200400174 · Cited by 99
Pietzonka, P., Rothen‐Rutishauser, B., Langguth, P., Wunderli‐Allenspach, H., Walter, E., & Merkle, H. P. (2002) · Pharmaceutical Research · doi:10.1023/a:1015393710253 · Cited by 97
Hussain, N., & Florence, A. T. (1998) · Pharmaceutical Research · doi:10.1023/a:1011981610840 · Cited by 94
Persorption of Particles: Physiology and Pharmacology
Volkheimer, G. (1977) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60188-x · Cited by 94
The Potential of Liposomes in Oral Drug Delivery
Rogers, J. A., & Anderson, K. E. (1998) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v15.i5.10 · Cited by 94
Ling, S. S. N., Magosso, E., Khan, N. A. K., Yuen, K. H., & Barker, S. A. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040500519102 · Cited by 93
Recent Advances in Intestinal Macromolecular Drug Delivery via Receptor-Mediated Transport Pathways
Swaan, P. W. (1998) · Pharmaceutical Research · doi:10.1023/a:1011908128045 · Cited by 91
Minato, S., Iwanaga, K., Kakemi, M., Yamashita, S., & Oku, N. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00093-2 · Cited by 87
Novel drug nanocarriers combining hydrophilic cyclodextrins and chitosan
Trapani, A., García-Fuentes, M., & Alonso, M. J. (2008) · Nanotechnology · doi:10.1088/0957-4484/19/18/185101 · Cited by 86
Transport mechanisms of mmePEG750P(CL-co-TMC) polymeric micelles across the intestinal barrier
Mathot, F., Rieux, A. D., Ariën, A., Schneider, Y., Brewster, M. E., & Véronique Préat, A. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.001 · Cited by 86
Quantum dots for tracking cellular transport of lectin-functionalized nanoparticles
Gao, X., Wang, T., Wu, B., Chen, J., Chen, J.-Y., Yue, Y., Dai, N., Chen, H., & Jiang, X. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.077 · Cited by 85
Andrieux, K., Forte, L., Lesieur, S., Paternostre, M., Ollivon, M., & Grabielle-Madelmont, C. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.004 · Cited by 85
Ramachandran, R., Paul, W., & Sharma, C. P. (2008) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31241 · Cited by 84
Krauel, K., Davies, N. M., Hook, S. M., & Rades, T. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.013 · Cited by 83
Gullberg, E., Keita, Å. V., Salim, S. Y., Andersson, M., Caldwell, K. D., Söderholm, J. D., & Artursson, P. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107847 · Cited by 83
Caveolin is present in intestinal cells: role in cholesterol trafficking?
Field, F. J., Born, E. J., Murthy, S., & Mathur, S. N. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32492-5 · Cited by 83
Lipka, E., & Amidon, G. L. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00022-x · Cited by 81
The preparation and characterization of polymeric antigen delivery systems for oral administration
Singh, M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00044-1 · Cited by 81
Bioadhesive properties of pegylated nanoparticles
Yoncheva, K., Gómez, S., Campanero, M. Á., Gamazo, C., & Irache, J. M. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.2.205 · Cited by 81
Formulation and Evaluation of a Folic Acid Receptor-Targeted Oral Vancomycin Liposomal Dosage Form
Anderson, K. E., Eliot, L., Stevenson, B. R., & Rogers, J. A. (2001) · Pharmaceutical Research · doi:10.1023/a:1011002913601 · Cited by 79
Self-assembled nanoparticles of poly(lactide)–Vitamin E TPGS copolymers for oral chemotherapy
ZHANG, Z., & FENG, S. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.013 · Cited by 79
The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles
Samstein, R. M., Perica, K., Balderrama, F., Look, M., & Fahmy, T. M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.10.026 · Cited by 79
Implication of nanoparticles/microparticles in mucosal vaccine delivery
Vyas, S. P., & Gupta, P. N. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.3.401 · Cited by 78
Pinto‐Alphandary, H., Aboubakar, M., Jaillard, D., Couvreur, P., & Vauthier, C. (2003) · Pharmaceutical Research · doi:10.1023/a:1024470508758 · Cited by 75
Leroux, J., Cozens, R. M., Roesel, J. L., Galli, B., Kubel, F., Doelker, É., & Gurny, R. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600841202 · Cited by 75
Oral vaccination in man using antigens in particles: current status
Brayden, D. J. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00175-0 · Cited by 72
Jantratid, E., Janssen, N., Chokshi, H. P., Tang, K., & Dressman, J. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.12.010 · Cited by 71
Landry, F. (1996) · Biomaterials · doi:10.1016/0142-9612(96)86742-1 · Cited by 68
Bayındır, Z. S., Yüksel, N., & Baykara, T. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.09.030 · Cited by 67
Zha, L., Xu, Z., Wang, M. ‐., & Linbo, G. U. (2007) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2007.00718.x · Cited by 63
A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway
Mudhakir, D., Akita, H., Tan, E., & Harashima, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.020 · Cited by 61
Binding and Uptake of Wheat Germ Agglutinin-Grafted PLGA-Nanospheres by Caco-2 Monolayers
Weissenböck, A., Bogner, E., Wirth, M., & Gabor, F. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045247.09724.26 · Cited by 61
Exploiting receptor biology for oral vaccination with biodegradable particulates
Foster, N. M., & Hirst, B. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.009 · Cited by 60
Eliyahu, H., Joseph, A. Z., Schillemans, J. P., Azzam, T., Domb, A. J., & Barenholz, Y. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.001 · Cited by 59
“Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?☆
Medina‐Kauwe, L. K. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.009 · Cited by 58
Rieux, A. D., Fiévez, V., Momtaz, M., Detrembleur, C., Alonso, M. J., van Gelder, J., Cauvin, A. J., Schneider, Y., & Véronique Préat, A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.023 · Cited by 58
Ragnarsson, E., Schoultz, I., Gullberg, E., Carlsson, A. H., Tafazoli, F., Lerm, M., Magnusson, K., Söderholm, J. D., & Artursson, P. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.86 · Cited by 58
M cell-targeted delivery of vaccines and therapeutics
KuoLee, R., & Chen, W. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.6.693 · Cited by 57
Liposomes for oral administration of drugs.
Woodley, J. F. (1985) · PubMed · Cited by 56
Physiological considerations in the design of particulate dosage forms for oral vaccine delivery
Yeh, P. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00036-2 · Cited by 56
Potentiality of double liposomes containing salmon calcitonin as an oral dosage form
Yamabe, K., Katō, Y., Onishi, H., & Machida, Y. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00160-3 · Cited by 52
Lochner, N., Pittner, F., Wirth, M., & Gabor, F. (2003) · Pharmaceutical Research · doi:10.1023/a:1023406224028 · Cited by 51
Polyalkylcyanoacrylate nanocapsules increase the intestinal absorption of a lipophilic drug
Damgé, C., Aprahamian, M., Balboni, G., Hoeltzel, A., Andrieu, V., & Devissaguet, J. P. (1987) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(87)90146-3 · Cited by 45
Targeting approaches to oral drug delivery
Lambkin, I., & Pinilla, C. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.1.67 · Cited by 44
Sun, W., Zou, W., Huang, G., Li, A., & Zhang, N. (2008) · Journal of drug targeting · doi:10.1080/10611860801927598 · Cited by 44
Ileal Uptake of Polyalkylcyanoacrylate Nanocapsules in the Rat
Damgé, C., Aprahamian, M., Humbert, W., & Pinget, M. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001774967 · Cited by 40
Reorganization of lipid nanocapsules at air–water interface
Minkov, I. L., Ivanova, T., Panaiotov, I., Proust, J. E., & Saulnier, P. (2005) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2005.07.001 · Cited by 34
Passive diffusion of polymeric surfactants across lipid bilayers
Mathot, F., Schanck, A. N., Françoise Van Bambeke, A., Ariën, A., Noppe, M., Brewster, M. E., & Véronique Préat, A. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.015 · Cited by 27
Cited by
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
McClements, D. J., & Rao, J. (2011) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.559558 · Cited by 1,630
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
pH-Responsive Nanoparticles for Drug Delivery
Gao, W., Chan, J. M., & Farokhzad, O. C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100253e · Cited by 1,025
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art
Date, A. A., Hanes, J., & Ensign, L. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.016 · Cited by 539
Metadata
- Authors
- Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P.
- Venue
- Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2010-02
- Volume
- 5
- Issue
- 2
- Pages
- 287-306
- ISSN
- 1743-5889 (ISSN-L)
- 1748-6963
- OpenAlex
- W2017853225
- Cited by
- 324
- References
- 189
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.